iniuva GmbH

iniuva provides AI-driven solutions for orphan drug development. iniuva's strategy is to address protein misfolding as a common mechanism of hundreds of diseases by developing pharmacological chaperone (PC) drugs that correct protein misfolding. The iniuva solution pipeline consists of a proprietary AI-driven virtual platform combined with a unified wet lab platform for rapid and efficient PC drug discovery. Our platforms enable a significant reduction in drug development time and costs.